Weight-loss drugs, including GLP-1 medications, may lead to significant fuel cost savings for US airlines. The potential savings are estimated to be around $580 million per year, although one report suggests the amount could be over $500 million. The possible reduction in fuel costs is linked to the weight loss of Americans, which could result in lower fuel consumption by airlines.